Adarx Pharmaceuticals ADRX
$12.79 −$1.37 (-9.68%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.79 0.00%
Open$14.03
Prev close$14.16
Day range$12.63 – $14.87
Volume708.8K
Market cap$1.42B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$746,000.00+258.7% YoY
Operating profit-$29.89M-41.5% YoY
Net profit-$25.76M-42.4% YoY
Diluted EPS-$0.24-0.4% YoY
Free cash flow-$27.56M-108.8% YoY
Operating cash flow-$27.19M
Revenue, last 4 quarters
Net profit, last 4 quarters
Diluted EPS by quarter
Free cash flow by quarter
Profitability & balance sheet
Operating margin-1,735.0%
Net margin-1,434.1%
Return on assets-19.3%
Current ratio12.98
Liabilities / assets155.0%
Cash & investments$427.25M
Total debt$5.19M
Net cash (debt)$422.07M
Cash flow
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| -Change in Prepaid Assets | -$1.37M | $493,000.00 | -$3.69M | -$4.50M | $1.75M |
| Change in Working Capital | -$3.59M | -$1.36M | $329.81M | $330.53M | $1.64M |
| Depreciation & Depletion & Amortization | $735,000.00 | $720,000.00 | $2.33M | $626,000.00 | $514,000.00 |
| Net Income from Continuing Operations | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
| Net cash flow from continuing operations | -$27.19M | -$22.68M | $262.29M | $313.44M | -$12.71M |
| Operating Cash Flow | -$27.19M | -$22.68M | $262.29M | $313.44M | -$12.71M |
| -Change in Payables and Accrued Expense | $514,000.00 | $730,000.00 | $4.36M | $698,000.00 | $1.33M |
| Free Cash Flow | -$27.56M | -$22.76M | $259.35M | $312.45M | -$13.20M |
| Effect of Exchange Rate Changes | $47,000.00 | $61,000.00 | $23,000.00 | $18,000.00 | -$6,000.00 |
| Net Change in Cash | -$5.42M | -$2.72M | $52.46M | $50.36M | $1.24M |
| Net Investment Purchase and Sale | $22.13M | $20.04M | -$206.99M | -$262.17M | $14.44M |
| Financing Cash Flow | $6,000.00 | $2,000.00 | $97,000.00 | $83,000.00 | $0.00 |
| Net Cash Flow from Continuing Financing Activities | $6,000.00 | $2,000.00 | $97,000.00 | $83,000.00 | $0.00 |
| Beginning Cash Balance | $63.86M | $66.52M | $14.03M | $15.27M | $14.03M |
| Net PPE Purchase and Sale | -$367,000.00 | -$77,000.00 | -$2.94M | -$992,000.00 | -$497,000.00 |
| Ending Cash Balance | $58.48M | $63.86M | $66.52M | $65.65M | $15.27M |
| Net Cash Flow from Continuing Investing Activities | $21.76M | $19.96M | -$209.93M | -$263.17M | $13.94M |
| Proceeds from Stock Option Exercised | $6,000.00 | $2,000.00 | $97,000.00 | $83,000.00 | $0.00 |
| Net cash flow from investing | $21.76M | $19.96M | -$209.93M | -$263.17M | $13.94M |
| -Change In Other Working Capital | -$746,000.00 | -$2.14M | $331.55M | – | – |
| -Change in Other Current Liabilities | -$430,000.00 | -$412,000.00 | -$862,000.00 | -$370,000.00 | -$128,000.00 |
| -Change in Other Current Assets | -$1.57M | -$30,000.00 | -$1.55M | -$91,000.00 | -$1.32M |
Income statement
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Non-Operating Interest Income | $3.78M | $3.98M | $13.64M | $2.48M | $2.27M |
| Other Income (Expense) | $355,000.00 | $411,000.00 | $1.64M | $553,000.00 | $72,000.00 |
| Other Non-Operating Income (Expenses) | $355,000.00 | $411,000.00 | $1.64M | $553,000.00 | $72,000.00 |
| Pretax Profit | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
| Net Income to Parent Company | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
| Net Income to Common Stockholders | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
| Basic EPS | -$0.24 | -$0.21 | -$0.97 | -$0.24 | -$0.21 |
| Diluted EPS | -$0.24 | -$0.21 | -$0.97 | -$0.24 | -$0.21 |
| Net Non-Operating Interest Income (Expense) | $3.78M | $3.98M | $13.64M | $2.48M | $2.27M |
| Operating Profit | -$29.89M | -$27.06M | -$88.37M | -$21.12M | -$17.89M |
| Profit from Continuing Operations | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
| Total Revenue as Reported | $746,000.00 | $2.14M | $3.45M | $208,000.00 | $0.00 |
| Total Operating Revenue | $746,000.00 | $2.14M | $3.45M | $208,000.00 | $0.00 |
| Operating Expense | $30.64M | $29.20M | $91.81M | $21.33M | $17.89M |
| Selling and Admin Expenses | $5.90M | $5.62M | $20.30M | $4.26M | $5.00M |
| -General & Admin Expense | $5.90M | $5.62M | $20.30M | $4.26M | $5.00M |
| Research & Development | $24.74M | $23.58M | $71.51M | $17.07M | $12.89M |
| Net Profit | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
Balance sheet
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|---|---|
| Cash and Cash Equivalents & Short-Term Investments | $427.25M | $455.82M | $480.00M | $219.48M |
| Gains/Losses Not Affecting Retained Earnings | -$783,000.00 | $306,000.00 | $1.96M | $335,000.00 |
| Retained Earnings | -$269.13M | -$243.37M | -$220.70M | -$147.61M |
| Additional Paid-In Capital | $18.86M | $17.33M | $16.49M | $10.13M |
| -Common Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| -Accounts Payable | $4.86M | $6.77M | $5.84M | $1.35M |
| Payables | $4.86M | $6.77M | $5.84M | $1.35M |
| Total Current Liabilities | $34.01M | $29.76M | $30.49M | $8.94M |
| Total Liabilities | $707.38M | $708.29M | $709.91M | $370.60M |
| Other Non-Current Assets | $3.81M | $2.24M | $2.21M | $660,000.00 |
| -Accumulated Depreciation | -$4.13M | -$3.84M | -$3.54M | -$2.54M |
| -Gross PPE | $15.11M | $15.44M | $15.61M | $9.67M |
| Net PPE | $10.98M | $11.60M | $12.07M | $7.13M |
| Total Non-Current Assets | $14.79M | $13.84M | $14.28M | $7.79M |
| Other Current Assets | $14.29M | $12.90M | $13.38M | $6.19M |
| -Short Term Investments | $368.77M | $391.96M | $413.48M | $205.44M |
| Total Assets | $456.33M | $482.56M | $507.66M | $233.45M |
| Current Accrued Expenses | $5.36M | $4.33M | $3.49M | $3.50M |
| Short-Term Debt and Capital Lease Obligation | $1.71M | $1.71M | $1.71M | $794,000.00 |
| Capital Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Stockholders' Equity | -$251.05M | -$225.73M | -$202.26M | -$137.15M |
| Total Equity | -$251.05M | -$225.73M | -$202.26M | -$137.15M |
| Other Non-Current Liabilities | $805,000.00 | $801,000.00 | $781,000.00 | $505,000.00 |
| Convertible preferred securities | $357.62M | $357.62M | $357.62M | $357.62M |
| Non-Current Deferred Liabilities | $309.76M | $314.50M | $314.99M | $0.00 |
| -Long Term Capital Lease Obligation | $5.19M | $5.62M | $6.03M | $3.54M |
| Total Current Assets | $441.54M | $468.72M | $493.38M | $225.67M |
| Long Term Debt and Capital Lease Obligation | $5.19M | $5.62M | $6.03M | $3.54M |
| Total Non-Current Liabilities | $673.37M | $678.54M | $679.43M | $361.66M |
| Current Deferred Liabilities | $18.91M | $14.92M | $16.56M | $0.00 |
| -Current Capital Lease Obligation | $1.71M | $1.71M | $1.71M | $794,000.00 |
| -Cash and Cash Equivalents | $58.48M | $63.86M | $66.52M | $14.03M |
No comments yet — be the first to weigh in on ADRX.
Sign in to join the discussion.